- Home
- BAND vs OLMA Comparison
BAND vs OLMA Comparison
Compare BAND & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAND
- OLMA
- Stock Information
- Founded
- BAND 2000
- OLMA 2006
- Country
- BAND United States
- OLMA United States
- Employees
- BAND N/A
- OLMA N/A
- Industry
- BAND Computer Software: Prepackaged Software
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- BAND Technology
- OLMA Health Care
- Exchange
- BAND Nasdaq
- OLMA Nasdaq
- Market Cap
- BAND 358.3M
- OLMA 299.7M
- IPO Year
- BAND 2017
- OLMA 2020
- Fundamental
- Price
- BAND $13.55
- OLMA $5.45
- Analyst Decision
- BAND Buy
- OLMA Strong Buy
- Analyst Count
- BAND 6
- OLMA 4
- Target Price
- BAND $20.80
- OLMA $24.50
- AVG Volume (30 Days)
- BAND 345.4K
- OLMA 429.0K
- Earning Date
- BAND 07-29-2025
- OLMA 08-12-2025
- Dividend Yield
- BAND N/A
- OLMA N/A
- EPS Growth
- BAND N/A
- OLMA N/A
- EPS
- BAND N/A
- OLMA N/A
- Revenue
- BAND $758,106,000.00
- OLMA N/A
- Revenue This Year
- BAND $2.36
- OLMA N/A
- Revenue Next Year
- BAND $13.56
- OLMA N/A
- P/E Ratio
- BAND N/A
- OLMA N/A
- Revenue Growth
- BAND 14.51
- OLMA N/A
- 52 Week Low
- BAND $11.33
- OLMA $2.86
- 52 Week High
- BAND $23.00
- OLMA $14.41
- Technical
- Relative Strength Index (RSI)
- BAND 38.62
- OLMA 60.98
- Support Level
- BAND $12.92
- OLMA $4.97
- Resistance Level
- BAND $16.45
- OLMA $5.40
- Average True Range (ATR)
- BAND 0.76
- OLMA 0.29
- MACD
- BAND -0.30
- OLMA 0.06
- Stochastic Oscillator
- BAND 15.04
- OLMA 76.70
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.